BetaShares DRUG ETF (ASX:DRUG)
The BetaShares DRUG ETF provides investors with exposure to leading global healthcare companies, hedged into Australian dollars.
DRUG share price & data
Prices updated using end of day data. Capital return only. FUM, fee and spread data updated monthly. Last updated: July 2020.
What does the DRUG invest in?
This ETF invests in well-known global healthcare companies like Johnson & Johnson, Novartis and Glaxosmithkline. This ETF could be a solution for investors looking for targeted exposure to the global healthcare sector.
What do investors use DRUG for?
DRUG could be used by investors looking for a tactical exposure to global healthcare companies, while reducing currency risk through hedging strategies.
DRUG dividend information
Distributions
DRP Status
Fund Issuer
Best ETFs warnings
The following warnings are applied by our team, based on quantitative metrics and our internal methodology. These risks are not exhaustive and therefore they should not be relied upon. Always read the PDS of the function and speak to your financial adviser before acting on this information.
Tax Domicile
Registry
Sector Information
Looking for something better?
This brilliant (and free!) report is issued by Best ETFs Australia, a division of The Rask Group Pty Ltd. It is not a recommendation.
Speak to a financial professional before relying on this information and please read our Financial Services Guide (FSG).
